| 000 | 01801 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250512195803.0 | ||
| 264 | 0 | _c19830107 | |
| 008 | 198301s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00352a007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChakrabarti, J K | |
| 245 | 0 | 0 |
_aEffects of conformationally restricted 4-piperazinyl-10H-thienobenzodiazepine neuroleptics on central dopaminergic and cholinergic systems. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cOct 1982 |
||
| 300 |
_a1133-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xchemical synthesis |
| 650 | 0 | 4 | _aBenzodiazepines |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 |
_aParasympathetic Nervous System _xdrug effects |
| 650 | 0 | 4 |
_aPhysostigmine _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Muscarinic _xdrug effects |
| 650 | 0 | 4 | _aSpectrophotometry, Infrared |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 650 | 0 | 4 | _aX-Ray Diffraction |
| 700 | 1 | _aHotten, T M | |
| 700 | 1 | _aMorgan, S E | |
| 700 | 1 | _aPullar, I A | |
| 700 | 1 | _aRackham, D M | |
| 700 | 1 | _aRisius, F C | |
| 700 | 1 | _aWedley, S | |
| 700 | 1 | _aChaney, M O | |
| 700 | 1 | _aJones, N D | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 25 _gno. 10 _gp. 1133-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00352a007 _zAvailable from publisher's website |
| 999 |
_c6128501 _d6128501 |
||